Champions Oncology, Inc. (CSBR) scores 37 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $6.79, representing a 17% margin of safety. Quantitative score: 55/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.